galactosamine has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aranda, ED; Martinez, A; Quero, Z; Rivas-Vetencourt, PA; Sorio, L; Vegas, AM; Zerpa, MJ | 1 |
| Bahjat, FR; Clare-Salzler, MJ; Crawford, JM; Dharnidharka, VR; Fukuzuka, K; Moldawer, LL; Morel, L | 1 |
2 other study(ies) available for galactosamine and Autoimmune Diabetes
| Article | Year |
|---|---|
Combined xenotransplantation of encapsulated hepatocytes and pancreatic islets.
Topics: Animals; Capsules; Cell Separation; Cell Transplantation; Diabetes Mellitus, Type 1; Galactosamine; Hepatectomy; Hepatic Encephalopathy; Islets of Langerhans; Islets of Langerhans Transplantation; Liver; Liver Function Tests; Liver, Artificial; Pancreas, Artificial; Pancreatectomy; Rats; Rats, Sprague-Dawley; Swine; Transplantation, Heterologous | 1997 |
Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Apoptosis; Cells, Cultured; Diabetes Mellitus, Type 1; Disease Susceptibility; fas Receptor; Female; Flow Cytometry; Galactosamine; Hepatocytes; Humans; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Proteins; Species Specificity; Tumor Necrosis Factor-alpha | 2000 |